AZ specialise in identifying novel chemical starting points for drug discovery programmes such as AWOL.

AZ know that innovation doesn’t happen in isolation, so they partner with others around the world, including academia, governments, industry and scientific organisations to access the best science and contribute complementary technologies, know-how and molecules.